Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAD52 | P43351 | 2/20 | 0.59 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | CXCR4 | P61073 | 5/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6493217 | 1.00 | RAD52 (0.59) | RAD52EPHX1GAASMN1; SMN2HTT | |
| SCHEMBL20614282 | 0.94 | RAD52 (0.58) | RAD52EPHX1GAASMN1; SMN2HTT | |
| SCHEMBL7947655 | 0.94 | RAD52 (0.58) | RAD52EPHX1GAASMN1; SMN2HTT | |
| SCHEMBL6973435 | 0.92 | RAD52 (0.55) | RAD52EPHX1GAASMN1; SMN2CXCR4 | |
| SCHEMBL13045564 | 0.87 | GAA (0.62) | RAD52EPHX1GAASMN1; SMN2LMNA | |
| SCHEMBL13771289 | 0.87 | GAA (0.62) | RAD52EPHX1GAASMN1; SMN2LMNA | |
| SCHEMBL7511788 | 0.87 | RAD52 (0.51) | RAD52EPHX1GAASMN1; SMN2HTT | |
| SCHEMBL20124124 | 0.87 | RAD52 (0.81) | RAD52EPHX1GAASMN1; SMN2CXCR4 | |
| SCHEMBL6975115 | 0.85 | GAA (0.60) | RAD52EPHX1GAASMN1; SMN2LMNA | |
| SCHEMBL7393711 | 0.82 | RAD52 (0.50) | RAD52CXCR4CXCL12HRH3CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050250743-A1 | Ammonium salts of inositol hexaphosphate, and uses thereof | LEHN JEAN-MARIE | 2005-11-10 | — | — | US | claimed |
| US-6610702-B2 | Supplying oxygen to tissues, organs | GMP OXYCELL, INC. | 2003-08-26 | — | — | US | claimed |
| US-20020173494-A1 | Ammonium salts of inositol hexaphosphate, and uses thereof | GMP OXYCELL, INC. | 2002-11-21 | — | — | US | claimed |
| WO-2002010177-A1 | AMMONIUM SALTS OF INOSITOL HEXAPHOSPHATE AND USES THEREOF | GMP COMPANIES, INC. (US) | 2002-02-07 | — | — | WO | claimed |
| US-20050250743-A1 | Ammonium salts of inositol hexaphosphate, and uses thereof | LEHN JEAN-MARIE | 2005-11-10 | — | — | US | disclosed |
| US-20050234096-A1 | Tetrahydroisoquinoline derivatives | BAYER HEALTHCARE AG (DE) | 2005-10-20 | — | — | US | disclosed |
| US-6610702-B2 | Supplying oxygen to tissues, organs | GMP OXYCELL, INC. | 2003-08-26 | — | — | US | disclosed |
| US-20020173494-A1 | Ammonium salts of inositol hexaphosphate, and uses thereof | GMP OXYCELL, INC. | 2002-11-21 | — | — | US | disclosed |
| WO-2002010177-A1 | AMMONIUM SALTS OF INOSITOL HEXAPHOSPHATE AND USES THEREOF | GMP COMPANIES, INC. (US) | 2002-02-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050250743-A1 | Ammonium salts of inositol hexaphosphate, and uses thereof | ITPA, PPIP5K2, INPP5B | RAD52 4278/4885EPHX1 2476/4885GAA 1234/4885 |
| US-20050234096-A1 | Tetrahydroisoquinoline derivatives | PPARD, PPARG, PPARA | RAD52 3054/4885EPHX1 1674/4885GAA 2179/4885 |
| US-20020173494-A1 | Ammonium salts of inositol hexaphosphate, and uses thereof | ITPA, PPIP5K2, INPP5B | RAD52 4278/4885EPHX1 2476/4885GAA 1234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.